{
    "title": "GSK profit falls short as cheap competition hits older drugs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7969523/GSK-profit-hit-pricing-pressure-sees-lower-2020-profit.html",
    "date": "2020-02-05",
    "keywords": [
        "company",
        "growth",
        "pushkala",
        "aripaka",
        "banerjee",
        "competition",
        "year",
        "patent",
        "prescription",
        "business",
        "programme",
        "gsk",
        "china",
        "profit",
        "pence",
        "share",
        "consensus",
        "httpswwwgskcomengbinvestorsanalystconsensusanalystconsensus",
        "wednesday",
        "chief",
        "executive",
        "emma",
        "firm",
        "oncology",
        "protection",
        "review",
        "dermatology",
        "merger",
        "overthecounter",
        "venture",
        "pfizer",
        "hiv",
        "role",
        "drug",
        "advair",
        "face",
        "pile",
        "incumbent",
        "result",
        "hyett",
        "equity",
        "analyst",
        "forecast",
        "impact",
        "coronavirus",
        "outbreak",
        "walmsley",
        "call",
        "novartis",
        "disruption",
        "term",
        "supply",
        "chain",
        "situation",
        "travel",
        "exchange",
        "drop",
        "estimate",
        "cash",
        "restructuring",
        "quarter",
        "ankur",
        "aakash",
        "jagadeesh",
        "babu",
        "bengaluru",
        "burger",
        "frankfurt",
        "editing",
        "bernard",
        "orr",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}